跳至主要内容
临床试验/NCT03636451
NCT03636451已完成3 期

Assessing the Effect of Paracervical Block Volume on Pain Control for Dilation and Curettage: a Randomized Controlled Trial

University of California, San Diego2 个研究点 分布在 1 个国家目标入组 114 人开始时间: 2018年10月29日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
入组人数
114
试验地点
2
主要终点
Pain With Cervical Dilation

研究概览

简要总结

The investigators are conducting a study on pain control for dilation and curettage (D&C). Participants are eligible to enroll if they are a planning to have a D&C in a participating clinic. The investigators are studying how different ratios of medication to liquid affect pain when injected around the cervix. Both potential methods use the same dose of medication, though researchers would like to know which one works better. To be in this study, participants must be over the age of 18 with an early pregnancy loss or undesired pregnancy measuring less than 12 weeks gestation undergoing D&C while awake in clinic.

详细描述

Dilation and Curettage (D&C) is often performed in the first trimester for surgical abortion and management of miscarriage and can be painful for patients before and after the procedure. Most procedures are performed while the patient is awake or with minimal sedation in the clinic setting, and a key component of pain control is the paracervical block, or injecting lidocaine into the tissue around the cervix. A paracervical block with 20cc of 1% buffered lidocaine has been proven to provide superior pain control than a sham paracervical block. However, many providers often use similar doses of lidocaine in a higher volume to improve pain control. At University of California, San Diego (UCSD) and University of California, Los Angeles (UCLA), some providers routinely use a 20cc of 1% buffered lidocaine block and some routinely use a 40cc of 0.5% buffered lidocaine block. This practice has not been studied in a randomized controlled trial. The purpose of this study is to compare pain control during D&C with a 20cc 1% buffered lidocaine with vasopressin paracervical block compared to a 40cc 0.5% buffered lidocaine with vasopressin paracervical block.

An inclusion criterion for this study is that patients must specifically be referred to family planning clinics at UCSD and UCLA for an in-clinic D&C. Therefore, the D&C is a required procedure for both study groups. The only difference in care between the study groups will be which paracervical block they receive.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

盲法说明

The study coordinator, who will be blinded to the intervention, will pick the designated sealed, opaque envelope containing the type of paracervical block and hand it to the physician performing the procedure. The physician will then open the envelope and prepare the designated paracervical block, as it is standard practice for physicians to prepare their own paracervical blocks prior to performing any D&C in-clinic. The paracervical block will contain 2U Vasopressin, 2cc of 8.4% sodium bicarbonate, and either 1% lidocaine or 0.5% lidocaine, depending on the study group. The physician will bring the paracervical block into the clinic room where the procedure will be performed on a covered tray. The physician will perform the standardized procedure for the D&C, and the study coordinator will assess pain control during the procedure.

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Women over the age of 18 presenting to UC San Diego and UC Los Angeles
  • Undesired pregnancy or missed abortion < 11 weeks 6 days gestation
  • Must speak English or Spanish
  • Desire surgical termination of pregnancy or management of miscarriage in clinic

排除标准

  • Women with a diagnosis of inevitable or incomplete abortion
  • Desire for general anesthesia or IV sedation
  • Chronic pain conditions
  • Any medical comorbidities that are a contraindication to performing the procedure in the clinic setting
  • Allergy to or refusal of ketorolac, oral Versed, or a paracervical block
  • If they have taken any pain medications the day of presentation to clinic
  • If they have taken Misoprostol the day of presentation to clinic

研究组 & 干预措施

40cc buffered 0.5% lidocaine with 2 units of vasopressin paracervical block

Experimental

40c buffered 0.5% lidocaine with 2 units of vasopressin paracervical block with dilation and curettage under minimal sedation

干预措施: 40cc buffered 0.5% lidocaine with 2 units of vasopressin paracervical block (Drug)

20cc 1% lidocaine with 2 units of vasopressin paracervical block

Active Comparator

20cc 1% lidocaine with 2 units of vasopressin paracervical block with dilation and curettage under minimal sedation

干预措施: 20cc 1% lidocaine with 2 units of vasopressin paracervical block (Drug)

结局指标

主要结局

Pain With Cervical Dilation

时间窗: Once during the procedure on the day of recruitment, approximately one minute. During procedure at time of cervical dilation.

Distance (mm) from the left of the 100-mm Visual Analog Scale (VAS) (reflecting magnitude of pain) recorded at time of cervical dilation. Pain will be assessed using a 100 mm visual analogue scale with the anchors 0 = none, 100 mm = worst imaginable.

次要结局

  • Pain 10 Minutes Post Procedure(Once 10 minutes after the procedure on the day of recruitment, approximately one minute.)
  • Pain With Uterine Aspiration(Once during the procedure on the day of recruitment, approximately 1 minute. During procedure immediately after uterine aspiration.)
  • Overall Pain(Once 10 minutes after the procedure on the day of recruitment, approximately one minute.)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Sheila Mody

Principal Investigator

University of California, San Diego

研究点 (2)

Loading locations...

相似试验